[SOU YI LIAN MEI NETWORK TECHNOLOGY (BEIJING) INDEX TONSOLIDATED FINANCIAL STATEMENTS Pages F-1nsolidated Balance Sheet of December 31, 2011 F-2nsolidated Statement ofome andmprehensiveome for the Year Ended December 31, 2011 F-3nsolidated Statement ofsh Flows for the Year Ended December 31, 2011]
[FORM 8-K/A (Amendment No. 4) CURRENT REPORT Date of Report (Date of earliest event reported): February 24, 2010 NF ENERGY SAVING Delaware 000-50155 02-0563302 (State or Other Jurisdiction of Incorporation) (IRS Employer Identification No.) Room 3105, Block C, 390 Qingnian Avenue, HePing District Shenyang, P.R. China 110021 (Zip Code) (8624) 8563-1159 (Former Name or Former Address, if Changed Since Last]
[FORM 8-K/A (Amendment No. 4) CURRENT REPORT Date of Report (Date of earliest event reported): February 24, 2010 NF ENERGY SAVING Delaware 000-50155 02-0563302 (State or Other Jurisdiction of Incorporation) (IRS Employer Identification No.) Room 3105, Block C, 390 Qingnian Avenue, HePing District Shenyang, P.R. China 110021 (Zip Code) (8624) 8563-1159 (Former Name or Former Address, if Changed Since Last]
[FORM 8-K/A (Amendment No. 4) CURRENT REPORTte of Report (Date of earliest event reported): February 24, 2010 NF ENERGYVING Delaware 000-50155 02-0563302 (State or Other Jurisdiction oforporation) (IRS Employer Identification No.) Room 3105, Block C, 390 Qingnian Avenue, HePing District Shenyang, P.R. China 110021 (Zipde) (8624) 8563-1159]
[BDO Tel: +852 2218 8288 Fax: +852 2815 2239 www.bdo.com.hk th 25 111 Connaught Road Central Hong Kong 100 F Street N.E. January 13, 2012 Our ref: 074238/ah1211/1301 Dear Sirs: RE: SKYPEOPLE FRUIT JUICE, INC. We have been furnished with a copy of the response to Item 4.01 of the Amendment to Form 8-K for the event that occurred on] [FORM 8-K/A (Amendment No. 1 to Form 8-K) CURRENT REPORT Date of Report (Date of earliest event reported): December 23, 2011 SkyPeople Fruit Juice, Inc. Florida 001-34502 98-0222013 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 16F, National Development Bank Tower, No. 2, Gaoxin 1st Road, Xi’an, China 710075 (Zip code) 86-29-88377216]
[BDO Tel: +852 2218 8288 Fax: +852 2815 2239 www.bdo.com.hk th 25 111 Connaught Road Central Hong Kong 100 F Street N.E. January 13, 2012 Our ref: 074238/ah1211/1301 Dear Sirs: RE: SKYPEOPLE FRUIT JUICE, INC. We have been furnished with a copy of the response to Item 4.01 of the Amendment to Form 8-K for the event that occurred on] [FORM 8-K/A (Amendment No. 1 to Form 8-K) CURRENT REPORT Date of Report (Date of earliest event reported): December 23, 2011 SkyPeople Fruit Juice, Inc. Florida 001-34502 98-0222013 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 16F, National Development Bank Tower, No. 2, Gaoxin 1st Road, Xi’an, China 710075 (Zip code) 86-29-88377216]
[Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. We hereby consent to your incorporation of our audit report dated December 23, 2011 relating to the audited financial statements of Shaanxi Weinan Aoxing Pharmaceuticals, LLC as of and for the year ended December 31, 2010 in Form 8-K/A of Biostar Pharmaceuticals, Inc. Certified] [Shaanxi Weinan Aoxing Pharmaceuticals, LLC (formerly Shaanxi Weinan Huaren Pharmaceuticals, Ltd.) Index to Financial Statements Year ended December 31, 2010 Page F-1 Balance Sheet F-2 Statement of Operations F-3 Statement of Stockholders’ Equity F-4 Statement of Cash Flows F-5 Notes to Financial Statements F-6 to F-16 To the Board of Directors Shaanxi Weinan Aoxing Pharmaceuticals, LLC (formerly Shaanxi Weinan Huaren] [UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS On October 11, 2011, Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) (“Biostar” or the “Company”), through its wholly owned variable interest entity, Shaanxi Aoxing Pharmaceutical Co., Ltd., acquired 100% equity interest (the “Acquisition”) of Shaanxi Weinan Aoxing Pharmaceutical, LLC (formerly Shaanxi Weinan Huaren Pharmaceutical, Ltd.) (“Shaanxi Weinan”) at a cash purchase consideration of RMB61]
[Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. We hereby consent to your incorporation of our audit report dated December 23, 2011 relating to the audited financial statements of Shaanxi Weinan Aoxing Pharmaceuticals, LLC as of and for the year ended December 31, 2010 in Form 8-K/A of Biostar Pharmaceuticals, Inc. Certified] [Shaanxi Weinan Aoxing Pharmaceuticals, LLC (formerly Shaanxi Weinan Huaren Pharmaceuticals, Ltd.) Index to Financial Statements Year ended December 31, 2010 Page F-1 Balance Sheet F-2 Statement of Operations F-3 Statement of Stockholders’ Equity F-4 Statement of Cash Flows F-5 Notes to Financial Statements F-6 to F-16 To the Board of Directors Shaanxi Weinan Aoxing Pharmaceuticals, LLC (formerly Shaanxi Weinan Huaren] [UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS On October 11, 2011, Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) (“Biostar” or the “Company”), through its wholly owned variable interest entity, Shaanxi Aoxing Pharmaceutical Co., Ltd., acquired 100% equity interest (the “Acquisition”) of Shaanxi Weinan Aoxing Pharmaceutical, LLC (formerly Shaanxi Weinan Huaren Pharmaceutical, Ltd.) (“Shaanxi Weinan”) at a cash purchase consideration of RMB61]
